Trial Profile
A phase I study of sorafenib/UFT chemotherapy in advanced hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Tegafur/uracil (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 05 Apr 2011 New trial record